Cargando…

Single-tablet regimens (STRs) enhance patients’ acceptability of HAART

Patients’ acceptability of HAART is a subjective variable that may deeply influence therapeutic outcome. The feeling of the patient may alter adherence and lead to virologic failure. Acceptability may depend on various variables often difficulty evaluated by the care-giver. In a clinical setting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggiolo, F, Fregosi, S, Bortolussi, P, Marcotullio, S, Murri, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512460/
http://dx.doi.org/10.7448/IAS.15.6.18103
_version_ 1782251731117146112
author Maggiolo, F
Fregosi, S
Bortolussi, P
Marcotullio, S
Murri, R
author_facet Maggiolo, F
Fregosi, S
Bortolussi, P
Marcotullio, S
Murri, R
author_sort Maggiolo, F
collection PubMed
description Patients’ acceptability of HAART is a subjective variable that may deeply influence therapeutic outcome. The feeling of the patient may alter adherence and lead to virologic failure. Acceptability may depend on various variables often difficulty evaluated by the care-giver. In a clinical setting the evaluation of acceptability is difficult, too, as patients may feel a judgement and be less sincere. Aim of this study was to asses adherence and acceptability of HAART. To limit reporting biases, the study was performed in five different non-clinic settings covering North and Central Italy. A total of 230 patients on stable HAART were asked to complete a semi-structured, anonymous questionnaire reporting their attitude toward HAART, their adherence and the acceptability of their regimen. In these notes we focus on this last patient-oriented outcome. Most of the subjects were males (66%) with a mean age of 46 years, with higher education level (72%) and a long history of HIV infection (mean 13.6 years). Consequently only 17% of patients were on a first-line regimen. Patients reporting a high or very high acceptability of HAART were 60% compared to a 31% reporting a fair grade of satisfaction and a 9% indicating low or null acceptability. However the type of the regimen significantly influenced patients’ acceptability. Single-tablet regimens (STRs), OD regimens with more than one tablet/day or BID regimens were scored as highly acceptable in 84%; 61%; and 53% of cases, respectively (P < 0.0001) (Figure). Statistical significance was retained when the dosing schedule was entered in a multivariate logistic model. When the analysis was restricted to experienced patients 62% of them were currently on a regimen based on a reduced number of pills compared to the previous one. Patients scored the previous regimen as more difficult to comply with in 72% of cases; as difficult in 22% and less difficult in 6%. The eventuality of AEs (40%); respect of timing of pill intake (39%) and number of pills (27%) were the major reasons of patients’ low acceptability of HAART. High acceptability is one of the winning characteristics of a regimen, favoring long-term adherence, durability and efficacy. Although highly subjective, acceptability may be positively influenced by characteristics of the HAART regimen such as simplicity. According to our results, STRs show a higher acceptability compared to more complex regimens.
format Online
Article
Text
id pubmed-3512460
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-35124602012-12-03 Single-tablet regimens (STRs) enhance patients’ acceptability of HAART Maggiolo, F Fregosi, S Bortolussi, P Marcotullio, S Murri, R J Int AIDS Soc Poster Abstract – P18 Patients’ acceptability of HAART is a subjective variable that may deeply influence therapeutic outcome. The feeling of the patient may alter adherence and lead to virologic failure. Acceptability may depend on various variables often difficulty evaluated by the care-giver. In a clinical setting the evaluation of acceptability is difficult, too, as patients may feel a judgement and be less sincere. Aim of this study was to asses adherence and acceptability of HAART. To limit reporting biases, the study was performed in five different non-clinic settings covering North and Central Italy. A total of 230 patients on stable HAART were asked to complete a semi-structured, anonymous questionnaire reporting their attitude toward HAART, their adherence and the acceptability of their regimen. In these notes we focus on this last patient-oriented outcome. Most of the subjects were males (66%) with a mean age of 46 years, with higher education level (72%) and a long history of HIV infection (mean 13.6 years). Consequently only 17% of patients were on a first-line regimen. Patients reporting a high or very high acceptability of HAART were 60% compared to a 31% reporting a fair grade of satisfaction and a 9% indicating low or null acceptability. However the type of the regimen significantly influenced patients’ acceptability. Single-tablet regimens (STRs), OD regimens with more than one tablet/day or BID regimens were scored as highly acceptable in 84%; 61%; and 53% of cases, respectively (P < 0.0001) (Figure). Statistical significance was retained when the dosing schedule was entered in a multivariate logistic model. When the analysis was restricted to experienced patients 62% of them were currently on a regimen based on a reduced number of pills compared to the previous one. Patients scored the previous regimen as more difficult to comply with in 72% of cases; as difficult in 22% and less difficult in 6%. The eventuality of AEs (40%); respect of timing of pill intake (39%) and number of pills (27%) were the major reasons of patients’ low acceptability of HAART. High acceptability is one of the winning characteristics of a regimen, favoring long-term adherence, durability and efficacy. Although highly subjective, acceptability may be positively influenced by characteristics of the HAART regimen such as simplicity. According to our results, STRs show a higher acceptability compared to more complex regimens. International AIDS Society 2012-11-11 /pmc/articles/PMC3512460/ http://dx.doi.org/10.7448/IAS.15.6.18103 Text en © 2012 Maggiolo F et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstract – P18
Maggiolo, F
Fregosi, S
Bortolussi, P
Marcotullio, S
Murri, R
Single-tablet regimens (STRs) enhance patients’ acceptability of HAART
title Single-tablet regimens (STRs) enhance patients’ acceptability of HAART
title_full Single-tablet regimens (STRs) enhance patients’ acceptability of HAART
title_fullStr Single-tablet regimens (STRs) enhance patients’ acceptability of HAART
title_full_unstemmed Single-tablet regimens (STRs) enhance patients’ acceptability of HAART
title_short Single-tablet regimens (STRs) enhance patients’ acceptability of HAART
title_sort single-tablet regimens (strs) enhance patients’ acceptability of haart
topic Poster Abstract – P18
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512460/
http://dx.doi.org/10.7448/IAS.15.6.18103
work_keys_str_mv AT maggiolof singletabletregimensstrsenhancepatientsacceptabilityofhaart
AT fregosis singletabletregimensstrsenhancepatientsacceptabilityofhaart
AT bortolussip singletabletregimensstrsenhancepatientsacceptabilityofhaart
AT marcotullios singletabletregimensstrsenhancepatientsacceptabilityofhaart
AT murrir singletabletregimensstrsenhancepatientsacceptabilityofhaart